Searched for
DRUG SAFETY AND EFFICACY
Zydus Semaglutide approval: Delhi HC directs CDSCO to decide on patient safety concernsThe Delhi High Court has asked the Central Drugs Standard Control Organisation to review a petition challenging Zydus Lifesciences' approva...- US stocks: Fulcrum shares plummet over 50% after scrapping lead sickle-cell drug on FDA concernsThe oral drug, pociredir, was being tested to treat sickle-cell disease, an inherited blood disorder that can trigger pain, anemia and or...
- Wockhardt shares rocket 19% after FDA approval for antibiotic targeting drug-resistant infections. Check detailsWockhardt's shares surged 19% after the U.S. FDA approved ZAYNICH, a novel intravenous antibiotic for complicated urinary tract infections....
- Japanese biotech developing tooth-regrowing drug raises $5.3 million to advance human trialsToregem BioPharma has secured $5.3 million to advance its experimental tooth-regeneration drug, TRG035, into Phase II clinical trials. The ...
- Wockhardt gets CDSCO nod for Zaynich antibioticWockhardt Ltd has secured approval from the CDSCO for its new antibiotic, Zaynich. This drug is developed in India and will be used to trea...
- Dr Reddy’s launches oral semaglutide in IndiaDr Reddys Laboratories has launched its oral semaglutide biosimilar for type 2 diabetes in India. The drug, Obeda, is available in three ta...
- Roche brings 7-minute lung cancer shot to IndiaRoche Pharma India introduces a new injectable immunotherapy for lung cancer. This treatment takes only seven minutes, a significant reduct...
- Roche Pharma launches India’s first 7-minute injectable immunotherapy for lung cancerRoche Pharma has introduced Tecentriq, India's first under-the-skin immunotherapy for lung cancer. This new injection takes about seven min...
- Tata group’s Impetis out-licenses arthritis and autoimmune drugs to VyomeIn a significant move for medical innovation, Impetis Biosciences, a subsidiary of Tata group, has teamed up with Vyome Holdings from the U...
- Tooth regeneration therapy enters first human clinical trials in JapanA groundbreaking human trial in Japan is exploring a revolutionary treatment to regrow teeth. Researchers have identified a way to activate...
- Researchers develop sustainable method to boost active vitamin B12 in SpirulinaA scientific breakthrough offers a new way to produce vitamin B12. Researchers are using managed light on Spirulina, a blue-green algae. Th...
- Aurobindo Pharma arm CuraTeQ gets Health Canada nod for biosimilarAurobindo Pharma announced a significant development today. Its subsidiary, CuraTeQ Biologics, has received a compliance notice from Health...
- Aloe Vera Oil for Hair Growth Is Popular in California, But the Science Is More CarefulAloe vera oil is popular for its soothing effects on the scalp. However, scientific studies do not support its claims for hair growth. Whil...
- US to loosen marijuana rules in major shift for $47 billion industryThe United States Department of Justice is easing rules on certain marijuana items. The drug will be reclassified as less dangerous. This s...
- Has Donald Trump administration made Marijuana legal for medical or recreational use in U.S.? Shares of cannabis firms jump big in U.S. Stock MarketCannabis decision by the Federal Government Iargely legitimizes medical marijuana programs in the 40 states that have adopted them.
- Social media is abuzz with weight-loss drug retatrutide and longevity goals. What is the drug all about?A new weight-loss drug, retatrutide, is generating excitement. This investigational medicine targets three hormone receptors, offering a po...
- ET Impact: DCGI asks pharma cos to adhere to production quality standardsThe DCGI's move comes a few days after ET reported that industrial excipients are used in manufacturing medicines and over 50 companies man...
- Himachal Pradesh High Court stays Drug Controller General of India's order on combination drugsRegulator planned to ban those for which drugmakers have not filed safety and efficacy data by September 30.
- DCGI asks drug manufacturers to get clearance before August 30The drug controller had earlier directed the state drug controllers to withdraw 294 FDCs which got licences without approval of DCGI.
- Drug cos, govt set up panels to decide on combo drugsDrug companies and the govt have formed separate technical committees to jointly decide which of the 294 combination drugs can be phased ou...
Load More
